Cargando…

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients.

BACKGROUND: The association of allergic diseases, drug adverse reactions and elevated total immunoglobulin E (IgE) concentration in systemic lupus erythematosus patients remains controversial. The aim of the study was to investigate the prevalence of those features in active and inactive systemic lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wozniacka, Anna, Sysa-Jedrzejowska, Anna, Robak, Ewa, Samochocki, Zbigniew, Zak-Prelich, Malgorzata
Formato:	Texto
Lenguaje:	English
Publicado:	2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781602/ https://www.ncbi.nlm.nih.gov/pubmed/12775359 http://dx.doi.org/10.1080/0962935031000097709

Ejemplares similares

Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (2004)

Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus
por: Kaleta, Beata, et al.
Publicado: (2013)

Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration
por: Hawro, Tomasz, et al.
Publicado: (2010)

Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (1999)

Topical steroid therapy in atopic dermatitis in theory and practice
por: Jeziorkowska, Renata, et al.
Publicado: (2015)

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes
por: Robak, E., et al.
Publicado: (1996)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
por: Robak, Ewa, et al.
Publicado: (2003)

The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosus
por: Tokarska, Kamila, et al.
Publicado: (2019)

Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
por: Robak, E, et al.
Publicado: (2001)

Quality of life and satisfaction with life in SLE patients—the importance of clinical manifestations
por: Kulczycka, Lilianna, et al.
Publicado: (2010)

Antinuclear antibodies in rosacea patients
por: Woźniacka, Anna, et al.
Publicado: (2013)

Variability of the rs333 in Polish patients with lupus erythematosus
por: Mlicka, Dominika, et al.
Publicado: (2021)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
por: Robak, Ewa, et al.
Publicado: (2006)

Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis
por: Bogaczewicz, Jarosław, et al.
Publicado: (2016)

Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.
por: Waszczykowska, E, et al.
Publicado: (1999)

Morbus Behçet – a rare disease in Central Europe
por: Woźniacka, Anna, et al.
Publicado: (2015)

Cellulite: a cosmetic or systemic issue? Contemporary views on the etiopathogenesis of cellulite
por: Tokarska, Kamila, et al.
Publicado: (2018)

X-linked TLR7 gene polymorphisms are associated with diverse immunological conditions but not with discoid lupus erythematosus in Polish patients
por: Skonieczna, Katarzyna, et al.
Publicado: (2018)

Neonatal lupus erythematosus – prevention is better than cure
por: Liszewska, Agata, et al.
Publicado: (2022)

Repeated Doses of UVR Cause Minor Alteration in Cytokine Serum Levels in Humans
por: Narbutt, Joanna, et al.
Publicado: (2005)

Immunometabolic disorders in the pathogenesis of systemic lupus erythematosus
por: Tokarska, Kamila, et al.
Publicado: (2019)

Changes of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus
por: Bogaczewicz, Jaroslaw, et al.
Publicado: (2019)

Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndrome
por: Juczynska, Katarzyna, et al.
Publicado: (2017)

Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
por: Klonowska-Szymczyk, Agnieszka, et al.
Publicado: (2014)

Methotrexate use and NAD(+)/NADH metabolism in psoriatic keratinocytes
por: Liszewska, Agata, et al.
Publicado: (2020)

Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
por: AlQadri, Nada G, et al.
Publicado: (2020)

Primary cutaneous CD4+ small‐/medium‐sized T‐cell lymphoproliferative disorder: A case report
por: Koper, Monika, et al.
Publicado: (2019)

Exhaled IL-8 in Systemic Lupus Erythematosus with and without Pulmonary Fibrosis
por: Nielepkowicz-Goździńska, Agnieszka, et al.
Publicado: (2014)

Expression of Selected Integrins and Selectins in Bullous Pemphigoid
por: Żebrowska, Agnieszka, et al.
Publicado: (2007)

Psoriatic Arthritis: Development, Detection and Prevention: A Scoping Review
por: Kimak, Agnieszka, et al.
Publicado: (2023)

The preliminary association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish population
por: Kaleta, Beata, et al.
Publicado: (2020)

Cambridge Neuropsychological Test Automated Battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile
por: Bogaczewicz, Anna, et al.
Publicado: (2015)

Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus
por: Fraser, Louise D., et al.
Publicado: (2015)

Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency
por: Beernaert, Laetitia, et al.
Publicado: (2020)

Interleukin 6 and 8 Levels in Plasma and Fibroblast Cultures in Psoriasis
por: Zalewska, Anna, et al.
Publicado: (2006)

Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-β2GPI Antibodies in Patients with Systemic Lupus Erythematosus
por: Hawro, Tomasz, et al.
Publicado: (2015)

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
por: Hennessey, Ashleigh, et al.
Publicado: (2019)

Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement.
por: Dziankowska-Bartkowiak, Bozena, et al.
Publicado: (2003)

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2005)

Can evaluation of specific immunoglobulin E serum concentrations of antibodies to aeroallergens in atopic dermatitis patients replace skin prick tests method in clinical practice?
por: Jeziorkowska, Renata, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k7gjmoi95bun4a8ro13qivehut